SUTRO BIOPHARMA, INC.·4

Sep 28, 6:53 PM ET

Shabbir Anik 4

4 · SUTRO BIOPHARMA, INC. · Filed Sep 28, 2021

Insider Transaction Report

Form 4
Period: 2021-09-24
Shabbir Anik
Chief Technical Ops. Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2021-09-248,6090 total
    Exp: 2021-09-26Common Stock (8,609 underlying)
  • Tax Payment

    Common Stock

    2021-09-24$19.23/sh2,976$57,22819,553 total
  • Exercise/Conversion

    Common Stock

    2021-09-24+8,60922,529 total
Footnotes (3)
  • [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
  • [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
  • [F3]The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION